GlassScriptPhysician profile
Lauren M Mancuso
NPI 1760899769
$3,844.26
in general payments reported to CMS, 2019-2025
21 companies · $1,477 in 2025
The $1,477 reported for 2025 was more than what 89% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,090 · 2022: $552 · 2023: $522 · 2024: $205 · 2025: $1,477.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,134 · Education: $68.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,133.73 |
| Education | $68.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,068.06 | 2021-2025 | |
| Pfizer INC. | $341.09 | 2021-2025 | |
| Genzyme Corporation | $326.35 | 2021-2025 | |
| Galderma Laboratories, L.P. | $231.77 | 2021-2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $230.37 | 2022-2023 | Sotyktu |
| Lilly USA, LLC | $208.26 | 2022-2025 | Ebglyss, Taltz |
| Novartis Pharmaceuticals Corporation | $191.30 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $190.85 | 2021-2025 | Dupixent |
| Vyne Pharmaceuticals INC. | $170.41 | 2021 | |
| Ucb, INC. | $138.07 | 2025 | Bimzelx |
| Arcutis Biotherapeutics, INC. | $130.19 | 2023-2025 | Zoryve |
| Sanofi US Services INC. | $124.99 | 2025 | |
| Incyte Corporation | $119.42 | 2022-2025 | Opzelura, Opzelura |
| Janssen Biotech, INC. | $99.11 | 2025 | Tremfya |
| Amgen INC. | $74.65 | 2021-2025 | Otezla |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $65.07 | 2021-2025 | |
| Organon LLC | $46.75 | 2025 | Nexplanon, Vtama |
| Blueprint Medicines Corporation | $27.47 | 2025 | Ayvakit |
| Leo Pharma INC. | $24.18 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.22 | 2022 | |
| Biofrontera INC. | $17.68 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lauren Mancuso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.